Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Dalbergin (6-Hydroxy-7-Methoxy-4-Phenylcoumarin) exhibits similar bone conserving effect against bone-loss as estradiol treatment, it as a therapeutic candidate against postmenopausal osteoporosis. 2. Dalbergin prevents some effects of photoaging and maintain skin integrity by regulating the degradation of the extracellular matrix proteins.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 108.00 | |
5 mg | In stock | $ 266.00 | |
10 mg | In stock | $ 393.00 | |
25 mg | In stock | $ 659.00 | |
50 mg | In stock | $ 939.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 195.00 |
Description | 1. Dalbergin (6-Hydroxy-7-Methoxy-4-Phenylcoumarin) exhibits similar bone conserving effect against bone-loss as estradiol treatment, it as a therapeutic candidate against postmenopausal osteoporosis. 2. Dalbergin prevents some effects of photoaging and maintain skin integrity by regulating the degradation of the extracellular matrix proteins. |
Source |
Synonyms | 6-Hydroxy-7-Methoxy-4-Phenylcoumarin |
Molecular Weight | 268.26 |
Formula | C16H12O4 |
CAS No. | 482-83-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (37.28 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dalbergin 482-83-7 Others inhibit Inhibitor 6-Hydroxy-7-Methoxy-4-Phenylcoumarin inhibitor